Abstrak
Since the year 2000 there has been a sharp increased in the number of HIV/AIDS patients in Indonesia. It is estimated that between 80.000 and 120.000 persons are currently infected with HIV, coming mostly from intravenous drug users. 1 Treatment with antiretroviral drugs (reverse-transcriptase inhibitors, protease inhibitors etc) when used as part of combination drug regimens, can profoundly suppress viral replication, with consequent repletion of CD4. The combination of anti retroviral drugs has been demonstrated to slow the progression of HIV type 1 (HIV-1) disease dramatically and to lower mortality among adults cases 2 , children and adolescents 3 infected with HIV-1. Clinical trials have shown the efficacy of the highly active antiretroviral-drug combinations 3, 4, 5, 6, 7, 8 by measuring the plasma load of HIV RNA and CD4+ cell counts.
It was important to identify subgroups of HIV infections, in which the anti retroviral treatment should be started (Table 1 ). The first clinical cathegory is symptomatic HIV patients (wasting, prolonged fever, thrush). There was consensus that these patients should be treated with antiretroviral therapy. 9 The second clinical category is HIV infected patients without clinical symptoms. Consideration for starting antiretroviral therapy in the second group is more complex. The risk of opportunistic infections increases markedly when CD4 cell count less than 200 per cubic millimeter and it is strongly supported that this group of patients should be offered antiretroviral therapy. 5, 9 There was theoretical benefit of antiretroviral therapy for patients with CD4 above 200 per cubic millimeter. The other clinical category is HIV patients with more than 350 CD4 cells/mm3 but plasma HIV RNA is more than 55,000 copies/ml. This group should be offered antiretroviral therapy, because the risk of progression to AIDS is very high. The purpose of this study was to evaluate whether there is a subgroup of asymptomatic HIV infection in drug users with normal CD4 cells count who might benefit from early antiretroviral therapy. The correlation between CD4 and viral load among drug users with normal CD4 cells count (more than 200 cells/mm 3 ) was performed in order to know whether CD4 count can be used as predictors of viral load.
METHODS
Patients with asymptomatic HIV-1 infection from drug users and having more than 200 CD4+ lymphocytes per cubic millimeter were enrolled in this study. The patients were recruited from various hospital in Jakarta between November 1999 till August 2001. CD4 and viral load were examined in 56 HIV/AIDS patients. CD4 testing was performed by indirect immunoflouresence method using monoclonal antibody, and viral load was tested using PCR technique (Amplicor HIV-1 Monitor assay version 1.5, Roche Molecular System, Branchburg NJ). All the samples for a given patient were retrieved and analyzed at the HematologyMedical Oncology Department of Internal Medicine, University of Indonesia.
HIV-1 RNA PCR
Plasma specimens were collected and stored at -20°C. Two hundred microlitres of each plasma samples were assayed on the same plate with three controls (negative, low positive and high positive control) in each assay. RNA was extracted from the plasma sample by the standard specimen preparation procedure, RNA is isolated directly from plasma by lysis of virus particles with a chaotropic agent followed by precipitation of the RNA with alcohol. Copy numbers of each plasma sample were calculated on the basis of the optical density readout of the final ELISA hybridization detection of amplicon and then adjusted for the efficiency of extraction, reverse trancription, and amplification of an internal target control sequence. The optical density (OD) was measured at 450 nm. The HIV-1 RNA level is calculated according to the equation:
Total HIV-1 OD X Input HIV-1 QS copies/PCR x 40 = Total QS OD HIV-1 RNA copies/ml
Data Collection and Statistical Analysis
The plasma HIV-1 detection range was 400-750,000 copies/ml (OD values 0.20-2.0). Test results less than 400 was reported as "HIV-1 RNA not detected", less than 400 copies/ml". Test results greater than 750,000 was reported as "greater than 750,000 copies/ml". In this case, the original plasma specimen should be diluted with HIV negative human plasma and retested to know the quantitative results.
We used Spearman correlation to investigate the association between the level of CD4 count and viral load count. All data was analyzed using SPSS 10.0 for Windows.
RESULTS
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DISCUSSION
Ongoing HIV replication leads to immune system damage and progression to AIDS. HIV infection is always harmful, and without treatment, true long-term survival, free of clinically significant immune dysfunction, is unusual. Plasma HIV RNA levels indicate the magnitude of HIV replication and is associated with the rate of CD4+ T cell destruction, whereas CD4+ T cell counts indicate the extent of HIV-induced immune damage.
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In this study, we evaluated that there was no negative correlation between plasma HIV-1 RNA viral load and CD4 cells count in drug users group. More than half of the drug users with asymptomatic HIV infection (55.4%) with normal CD4 counts (more than 200 cells/mm 3 ) had high plasma HIV RNA level. ACTG 175, a multicenter study in HIV patients with 200-500 CD4 cells/mm 3 conducted by Lathey et al, showed that viral load was inversely corelated with CD4 cell number. 12 In this multicenter study the patients were not grouped according to the way of transmission.
Previous studies showed that there were different underlying conditions in drug users group, e.g. coinfection with Hepatitis C and B virus, tuberculosis and endocarditis. These conditions might facilitate high replication of HIV by direct interaction between 2 viruses 13 or secondary effects resulted from the release of cellular factors in response to infection. 14, 15 Understanding the contribution of virologic measurement and CD4 + cells count as prognostic factor of the disease is very important for determining when to start antiretroviral therapy, as well as for evaluating the outcome of antiretroviral therapy. CD4 + cell counts are good indicators of immune function in HIV infection. Plasma HIV-1 RNA assays (viral load assays) are useful as indicator of the prognosis of HIV infection, for indicating when asymptomatic patients should be treated and as a reference for subsequent monitoring of the virological response to therapy. 16 Palella et.al showed that plasma HIV RNA levels provide more powerful predictors of risk of progression to AIDS and death than do CD4 + T cell levels; however, the combined measurement of the two values provides an even more accurate method to assess the prognosis of HIV-infected persons.
2 There is a relationship between baseline HIV RNA levels, measured in a large cohort of HIV-infected adults, and their subsequent rate of CD4 + T cell decline. 2 Progressive loss of CD4 + T cells is observed in all strata of baseline plasma HIV RNA concentrations, but substantially more rapid decline are seen in persons with higher baseline plasma HIV RNA level. Likewise, a clear gradient in risk for disease progression and death is seen with increasing baseline plasma HIV RNA levels. 2, 10, 17 Regular, periodic measurement of plasma HIV RNA levels and CD4 + T cell counts is necessary to determine the risk for disease progression in an HIV-infected person and to determine when to initiate or modify antiretroviral treatment regimens. As rates of disease progression differ among HIV-infected persons, treatment decisions should be individualized by level of risk indicated by plasma HIV RNA levels and CD4 + T cell counts.
Our study showed that majority of drug users with more than 200 CD4 cells/mm3 had high plasma HIV RNA level. Based on this fact we should offered the majority of HIV patients derived from drug users group to take antiretroviral therapy, although they still had high CD4 cells count level. We can suggest that in people living with HIV (PLWH) due to drug users, antiretroviral drugs should be started early although they have good clinical condition and had high level of CD4 + cells number.
Plasma HIV-1 viral load should be used to monitor the outcome of antiretroviral therapy. It had better value than CD4+ cell count in predicting the prognosis of HIV patients coming from injecting drug users.
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CONCLUSION
The management of PLWH came from drug user is different from the PLWH who had HIV from sexual transmission. The majority (56,14%) of asymptomatic HIV patients with normal CD4 counts, had high plasma HIV RNA level. Early anti retroviral treatment is suggested in those patients. The viral load examination is very important to monitor the result of the treatment.
